<table class="infobox infobox-protein"> <tr><th class="infobox-header" colspan="2">ERLIN2 Protein</th></tr> <tr><td class="label">Gene</td><td><a href="/genes/erlin2">ERLIN2</a></td></tr> <tr><td class="label">UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/O94905" target="_blank">O94905</a></td></tr> <tr><td class="label">Mol. Weight</td><td>37.8 kDa</td></tr> <tr><td class="label">Localization</td><td>Endoplasmic reticulum membrane</td></tr> <tr><td class="label">Family</td><td>Prohibitin domain family</td></tr> <tr><td class="label">Diseases</td><td><a href="/diseases/als">ALS</a>, Hereditary Spastic Paraplegia</td></tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td> </tr> </table>
ERLIN2 Protein (ER Lipid Raft Associated 2)
Introduction Erlin2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview ERLIN2 is an endoplasmic reticulum (ER) membrane protein encoded by the [ERLIN2 gene](/genes/erlin2). It forms a complex with ERLIN1 and plays essential roles in ER-associated degradation (ERAD), lipid metabolism, and cellular stress responses.
Structure ERLIN2 contains several key structural domains:
SPFH (stomatin/prohibitin/flotillin/HflK/C) domain : Core functional domain
Transmembrane domains : Anchors the protein to the ER membrane
Coiled-coil regions : Mediates oligomerization with ERLIN1
...
<table class="infobox infobox-protein"> <tr><th class="infobox-header" colspan="2">ERLIN2 Protein</th></tr> <tr><td class="label">Gene</td><td><a href="/genes/erlin2">ERLIN2</a></td></tr> <tr><td class="label">UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/O94905" target="_blank">O94905</a></td></tr> <tr><td class="label">Mol. Weight</td><td>37.8 kDa</td></tr> <tr><td class="label">Localization</td><td>Endoplasmic reticulum membrane</td></tr> <tr><td class="label">Family</td><td>Prohibitin domain family</td></tr> <tr><td class="label">Diseases</td><td><a href="/diseases/als">ALS</a>, Hereditary Spastic Paraplegia</td></tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td> </tr> </table>
ERLIN2 Protein (ER Lipid Raft Associated 2)
Introduction Erlin2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview ERLIN2 is an endoplasmic reticulum (ER) membrane protein encoded by the [ERLIN2 gene](/genes/erlin2). It forms a complex with ERLIN1 and plays essential roles in ER-associated degradation (ERAD), lipid metabolism, and cellular stress responses.
Structure ERLIN2 contains several key structural domains:
SPFH (stomatin/prohibitin/flotillin/HflK/C) domain : Core functional domain
Transmembrane domains : Anchors the protein to the ER membrane
Coiled-coil regions : Mediates oligomerization with ERLIN1
The protein forms ring-like complexes with ERLIN1, creating large oligomeric structures in the ER membrane.
Normal Function
ER-Associated Degradation (ERAD) ERLIN2 is a key component of ERAD:
Substrate recognition : Identifying misfolded proteins in the ER
Ubiquitination : Facilitating the ubiquitination of target proteins
Retrotranslocation : Assisting in the extraction of proteins from the ER
Proteasomal targeting : Directing substrates to the proteasome
IP3 Receptor Regulation A critical function of ERLIN2 is regulating IP3 receptors:
Mediating degradation : Triggering degradation of activated IP3R
Calcium homeostasis : Controlling calcium release from ER stores
Signal termination : Turning off calcium signaling
ERLIN2 participates in lipid regulation:
Cholesterol sensing : Responding to cellular cholesterol levels
Lipid raft maintenance : Preserving ER membrane microdomains
SREBP pathway : Modulating lipid biosynthesis
Role in Disease
Hereditary Spastic Paraplegia (HSP) ERLIN2 mutations cause autosomal recessive HSP:
Pathogenic Mechanisms
Loss of ERAD function
Accumulation of misfolded proteins
ER stress activation
Corticospinal tract degeneration
Clinical Features
Progressive lower limb spasticity
Weakness
Hyperreflexia
Variable cognitive involvement
Amyotrophic Lateral Sclerosis ERLIN2 contributes to ALS pathogenesis:
ER stress : Exacerbating motor neuron stress
Protein aggregation : Impaired clearance of [TDP-43](/proteins/tdp-43), SOD1
Calcium dysregulation : Disrupted calcium homeostasis
Selective vulnerability : Contributing to motor neuron death
Primary Lateral Sclerosis Some mutations cause PLS:
Upper motor neuron predominant
Slower progression than ALS
Preserved lower motor [neurons](/entities/neurons)
Therapeutic Targeting
Potential Strategies
ER stress reducers : Compounds that reduce ER stress
ERAD enhancers : Boosting protein degradation capacity
Calcium stabilizers : Normalizing calcium signaling
Gene therapy : Delivering functional ERLIN2
Research Directions
Chemical chaperones for ER stress
Modulators of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system)
Small molecules targeting ERLIN2 complexes
Key Publications
Alazami AM, et al. "ERLIN2 mutations in HSP." Am J Hum Genet 2011.
Pearce MM, et al. "ERLIN2 in ERAD." J Biol Chem 2009.
See Also
[ERLIN2 Gene](/genes/erlin2)
[ER Stress](/mechanisms/er-stress-pathway)mechanisms/er-stress-neurodegeneration)
[Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
[ER-Associated Degradation](/mechanisms/erad)
External Links
[UniProt: O94905](https://www.uniprot.org/uniprot/O94905)
[AlphaFold: ERLIN2](https://alphafold.ebi.ac.uk/entry/O94905)
Background The study of Erlin2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Alazami AM, et al, ERLIN2 mutations (2011)
Pearce MM, et al, ERLIN2 function (2009)
Show full description